The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mercaptopurine Silver Pharma 50 mg tablets

Silver Pharma S.L.PA23137/001/001

Main Information

Trade NameMercaptopurine Silver Pharma 50 mg tablets
Active SubstancesMercaptopurine
Dosage FormTablet
Licence HolderSilver Pharma S.L.
Licence NumberPA23137/001/001

Group Information

ATC CodeL01BB02 mercaptopurine


License statusAuthorised
Licence Issued02/07/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back